Tsubo K, Arai M, Omachi H, Mitamura K
Second Department of Internal Medicine, Showa University School of Medicine, Tokyo, Japan.
J Gastroenterol. 1996 Aug;31(4):578-81. doi: 10.1007/BF02355060.
We evaluated the effect of the specific cholecystokinin (CCK) receptor antagonist, loxiglumide, on gallbladder contractile function in guinea pigs. Five mg/kg body weight (BW) of loxiglumide was administered orally to guinea pigs once a day for 3 days. We then investigated gallbladder contractile function and plasma CCK concentrations in the guinea pigs. Maximal gallbladder pressure induced by cerulein was significantly depressed on the 1st and 3rd days following loxiglumide administration. On the 1st day, the plasma CCK concentration was significantly increased compared with that of the control group during fasting and 15 min after the administration of an intraduodenal test meal. These results suggest that the disturbed gallbladder contraction is due to the competitive inhibition of CCK by loxiglumide. Gallbladder contractile function in guinea pigs is depressed by loxiglumide; however, this effect is reversible after short-term loxiglumide administration.
我们评估了特异性胆囊收缩素(CCK)受体拮抗剂洛西丁胺对豚鼠胆囊收缩功能的影响。以5毫克/千克体重的剂量给豚鼠口服洛西丁胺,每天一次,持续3天。然后我们研究了豚鼠的胆囊收缩功能和血浆CCK浓度。在给予洛西丁胺后的第1天和第3天,由蛙皮素诱导的最大胆囊压力显著降低。在第1天,与对照组相比,禁食期间和十二指肠内给予试验餐15分钟后的血浆CCK浓度显著升高。这些结果表明,胆囊收缩紊乱是由于洛西丁胺对CCK的竞争性抑制所致。洛西丁胺可降低豚鼠的胆囊收缩功能;然而,在短期给予洛西丁胺后,这种作用是可逆的。